DE68925199T2 - Peptide und polypeptide stammend von den submaxillaren drüsen der ratte, deren entsprechende monoklonale und polyklonale antikörper entsprechende hybridomen und verwendung dieser verbindungen in der diagnose bei bestimmungen und für pharmazeutische zwecke - Google Patents

Peptide und polypeptide stammend von den submaxillaren drüsen der ratte, deren entsprechende monoklonale und polyklonale antikörper entsprechende hybridomen und verwendung dieser verbindungen in der diagnose bei bestimmungen und für pharmazeutische zwecke

Info

Publication number
DE68925199T2
DE68925199T2 DE68925199T DE68925199T DE68925199T2 DE 68925199 T2 DE68925199 T2 DE 68925199T2 DE 68925199 T DE68925199 T DE 68925199T DE 68925199 T DE68925199 T DE 68925199T DE 68925199 T2 DE68925199 T2 DE 68925199T2
Authority
DE
Germany
Prior art keywords
peptides
submaxillar
hybridomes
glands
determinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68925199T
Other languages
English (en)
Other versions
DE68925199D1 (de
Inventor
Isabelle Chupin
Diana Tronik
Francois Rougeon
Nabil Seidah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of DE68925199D1 publication Critical patent/DE68925199D1/de
Application granted granted Critical
Publication of DE68925199T2 publication Critical patent/DE68925199T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE68925199T 1988-10-11 1989-10-11 Peptide und polypeptide stammend von den submaxillaren drüsen der ratte, deren entsprechende monoklonale und polyklonale antikörper entsprechende hybridomen und verwendung dieser verbindungen in der diagnose bei bestimmungen und für pharmazeutische zwecke Expired - Lifetime DE68925199T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8813353A FR2637600B1 (fr) 1988-10-11 1988-10-11 Peptides et polypeptides provenant de la glande sous maxillaire du rat, anticorps monoclonaux et polyclonaux correspondants, hybridomes correspondants et applications de ces produits au diagnostic, a la detection ou a des fins therapeutiques
PCT/FR1989/000523 WO1990003981A1 (fr) 1988-10-11 1989-10-11 Peptides et polypeptides provenant de la glande sous maxillaire du rat, anticorps monoclonaux et polyclonaux correspondants, hybridomes correspondants et applications de ces produits au diagnostic, a la detection ou a des fins therapeutiques

Publications (2)

Publication Number Publication Date
DE68925199D1 DE68925199D1 (de) 1996-02-01
DE68925199T2 true DE68925199T2 (de) 1996-09-05

Family

ID=9370902

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68925199T Expired - Lifetime DE68925199T2 (de) 1988-10-11 1989-10-11 Peptide und polypeptide stammend von den submaxillaren drüsen der ratte, deren entsprechende monoklonale und polyklonale antikörper entsprechende hybridomen und verwendung dieser verbindungen in der diagnose bei bestimmungen und für pharmazeutische zwecke

Country Status (7)

Country Link
US (4) US5859189A (de)
EP (1) EP0394424B1 (de)
JP (1) JP2980334B2 (de)
AT (1) ATE131829T1 (de)
DE (1) DE68925199T2 (de)
FR (1) FR2637600B1 (de)
WO (1) WO1990003981A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589750B2 (en) * 1997-02-20 2003-07-08 Institut Pasteur Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives
JP2003512302A (ja) * 1999-06-23 2003-04-02 アンスティテュ パストゥール 障害性個人間及び行動障害の治療のための治療法及び組成物
DK1216707T3 (da) * 2000-12-22 2005-05-09 Pasteur Institut Fremgangsmåde til screening af ligandmolekyler, der specifikt binder til NEP-bindingsstederne for QHNPR-pentapeptidet
PL1577320T3 (pl) * 2004-03-19 2012-12-31 Pasteur Institut Peptydy pochodzące z ludzkiego białka BPLP, polinukleotydy kodujące te peptydy oraz przeciwciała skierowane przeciw tym peptydom
US7190757B2 (en) * 2004-05-21 2007-03-13 Analogic Corporation Method of and system for computing effective atomic number images in multi-energy computed tomography
US7136450B2 (en) * 2004-05-26 2006-11-14 Analogic Corporation Method of and system for adaptive scatter correction in multi-energy computed tomography
US7415147B2 (en) * 2004-06-04 2008-08-19 Analogic Corporation Method of and system for destreaking the photoelectric image in multi-energy computed tomography
US7327853B2 (en) * 2004-06-09 2008-02-05 Analogic Corporation Method of and system for extracting 3D bag images from continuously reconstructed 2D image slices in computed tomography
US7302083B2 (en) * 2004-07-01 2007-11-27 Analogic Corporation Method of and system for sharp object detection using computed tomography images
US7224763B2 (en) * 2004-07-27 2007-05-29 Analogic Corporation Method of and system for X-ray spectral correction in multi-energy computed tomography
US7388983B2 (en) * 2004-08-18 2008-06-17 Analogic Corporation Method of and system for detecting anomalies in projection images generated by computed tomography scanners
US7136451B2 (en) * 2004-10-05 2006-11-14 Analogic Corporation Method of and system for stabilizing high voltage power supply voltages in multi-energy computed tomography
US8009883B2 (en) * 2007-02-09 2011-08-30 Analogic Corporation Method of and system for automatic object display of volumetric computed tomography images for fast on-screen threat resolution
US7724866B2 (en) * 2007-06-27 2010-05-25 Analogic Corporation Method of and system for variable pitch computed tomography scanning for baggage screening
EP2265937A1 (de) 2008-03-27 2010-12-29 Analogic Corporation Verfahren und system für einen 3d-graphischen arbeitsplatz für sicherheits- und medizinische anwendungen
PT2274321T (pt) 2008-04-07 2019-03-21 Pasteur Institut Derivados do péptido opiorfina como inibidores potentes da encefalina ¿ degradação de ectopeptidades
FR2931362B1 (fr) 2008-05-26 2017-08-18 Pasteur Institut L'opiorphine pour une utilisation en tant que psychostimulant.
CA2645452A1 (en) * 2008-11-28 2010-05-28 Institut Pasteur Use of basic prolin-rich lacrimal gene products, such as opiorphin, as a biomarker

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56145222A (en) * 1980-04-28 1981-11-11 Toshiyuki Hamaoka Improved antibody and its preparation
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
DE3374170D1 (en) * 1982-05-06 1987-12-03 Massachusetts Inst Technology Production of enterovirus neutralizing antibodies from vp1
IE56509B1 (en) * 1982-11-04 1991-08-28 Univ California Methods for oncogenic detection
US4699877A (en) * 1982-11-04 1987-10-13 The Regents Of The University Of California Methods and compositions for detecting human tumors
GB8327966D0 (en) * 1983-10-19 1983-11-23 Nyegaard & Co As Chemical compounds
US4669877A (en) * 1985-02-22 1987-06-02 The Perkin-Elmer Corporation Digital gain controlled current to voltage amplifier
US4886747A (en) * 1985-03-22 1989-12-12 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
FI100106B (fi) * 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi

Also Published As

Publication number Publication date
ATE131829T1 (de) 1996-01-15
WO1990003981A1 (fr) 1990-04-19
US20030170620A1 (en) 2003-09-11
FR2637600A1 (fr) 1990-04-13
EP0394424B1 (de) 1995-12-20
EP0394424A1 (de) 1990-10-31
DE68925199D1 (de) 1996-02-01
JP2980334B2 (ja) 1999-11-22
US6025143A (en) 2000-02-15
US6916607B2 (en) 2005-07-12
FR2637600B1 (fr) 1992-03-06
US20050153374A1 (en) 2005-07-14
US5859189A (en) 1999-01-12
JPH03501738A (ja) 1991-04-18

Similar Documents

Publication Publication Date Title
DE68925199T2 (de) Peptide und polypeptide stammend von den submaxillaren drüsen der ratte, deren entsprechende monoklonale und polyklonale antikörper entsprechende hybridomen und verwendung dieser verbindungen in der diagnose bei bestimmungen und für pharmazeutische zwecke
LU91087I2 (fr) Advate(Octocog alfa) soustotes ses formes protégées par le brevet de base.
DK0573545T3 (da) Monoklonale antistoffer mod receptor-inducerede bindingssteder
ATE98376T1 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
DE69535948D1 (de) Von wd-40 abstammende peptide und ihre verwendung
ATE177758T1 (de) Synthetische peptide, antikörper dagegen und ihre verwendung
DE3584209T2 (de) T-zellenrezeptor, spezifisch für antigenpolypeptide und verwandte polynukleotide.
ES8705919A1 (es) Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original.
AU564620B2 (en) Peptides and protein-peptide complexes
DE69033453T2 (de) Rekombinante Polypeptide und Peptide, dafür kodierende Nukleinsäuren und ihre Verwendung in der Tuberkulose-Diagnose
ES8802457A1 (es) Un procedimiento para la preparacion de polipeptidos inmunogenicos
DK109280A (da) Tripeptider og fremgangsmaade til fremstilling deraf
DE69315989T2 (de) Aminoterminale prokollagen 1(i) peptide
Bubb et al. Studies on the structural and biological functions of the Cμ3 and Cμ4 domains of IgM
DE69326145D1 (de) Synthetische peptide für die behandlung von myasthenia gravis
ATE180788T1 (de) Polypeptide mit einer aktivität des menschlichen dopaminergischen rezeptors, deren kodierende nukleinsäuresequenzen und verwendung dieser polypeptide
Fauchere A QSAR study of the inhibitory action of a series of enkephalin-like peptides in the guinea pig ileum and mouse vas deferens bioassays
Williams et al. Immunity in the Connective Tissue Diseases
FIBRINOGEN et al. A MONOCLONAL ANTIBODY AGAINST THE CNBR-PEPTIDE F-CB3 OF THE

Legal Events

Date Code Title Description
8364 No opposition during term of opposition